YahooAugust 24, 2026 at 3:47 PM NY10 days ago

Reasons to Retain Doximity Stock in Your Portfolio for Now

DOCS' AI expansion is opening new growth avenues, but rising AI costs and tight pharma budgets could temper near-term gains.

Read the Full Story at the Source

The summary here comes from the news provider; the rest of the article lives on the publisher's site — Yahoo

Companies in This Story